Related Experiment Video
Updated: Mar 26, 2026

Dissecting Multi-protein Signaling Complexes by Bimolecular Complementation Affinity Purification BiCAP
Published on: June 15, 2018
BS69/ZMYND11 C-Terminal Domains Bind and Inhibit EBNA2
Matthew R Harter1, Cheng-Der Liu2, Chih-Lung Shen2
1Department of Biochemistry, University of California, Riverside, Riverside, California, United States of America.
Abstract:
Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) plays an important role in driving immortalization of EBV-infected B cells through regulating the expression of many viral and cellular genes. We report a structural study of the tumor suppressor BS69/ZMYND11 C-terminal region, comprised of tandem coiled-coil-MYND domains (BS69CC-MYND), in complex with an EBNA2 peptide containing a PXLXP motif. The coiled-coil domain of BS69 self-associates to bring two separate MYND domains in close proximity, thereby enhancing the BS69 MYND-EBNA2 interaction. ITC analysis of BS69CC-MYND with a C-terminal fragment of EBNA2 further suggests that the BS69CC-MYND homodimer synergistically binds to the two EBNA2 PXLXP motifs that are respectively located in the conserved regions CR7 and CR8. Furthermore, we showed that EBNA2 interacts with BS69 and down-regulates its expression at both mRNA and protein levels in EBV-infected B cells. Ectopic BS69CC-MYND is recruited to viral target promoters through interactions with EBNA2, inhibits EBNA2-mediated transcription activation, and impairs proliferation of lymphoblastoid cell lines (LCLs). Substitution of critical residues in the MYND domain impairs the BS69-EBNA2 interaction and abolishes the BS69 inhibition of the EBNA2-mediated transactivation and LCL proliferation. This study identifies the BS69 C-terminal domains as an inhibitor of EBNA2, which may have important implications in development of novel therapeutic strategies against EBV infection.
Insights
The tumor suppressor BS69 inhibits Epstein-Barr virus nuclear antigen 2 (EBNA2) by binding to its PXLXP motifs. This interaction blocks EBNA2-driven B cell immortalization, offering potential therapeutic strategies for EBV infection.
Area of Science:
- Structural biology
- Virology
- Molecular oncology
Background:
- Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) is crucial for B cell immortalization by regulating viral and cellular gene expression.
- The tumor suppressor BS69 (also known as ZMYND11) interacts with EBNA2, influencing EBV-driven processes.
Purpose of the Study:
- To elucidate the structural basis of the interaction between the BS69 C-terminal region and EBNA2.
- To investigate the functional consequences of this interaction on EBNA2-mediated transcription and B cell proliferation.
Main Methods:
- X-ray crystallography to determine the structure of BS69CC-MYND in complex with an EBNA2 peptide.
- Isothermal Titration Calorimetry (ITC) to analyze binding affinities.
- Cell-based assays to assess EBNA2-mediated transcription activation and lymphoblastoid cell line (LCL) proliferation.
Main Results:
- The coiled-coil domain of BS69 self-associates, enhancing the binding of its MYND domains to EBNA2.
- BS69CC-MYND homodimers bind synergistically to two PXLXP motifs in EBNA2 (CR7 and CR8).
- EBNA2 down-regulates BS69 expression in infected B cells. Ectopic BS69CC-MYND inhibits EBNA2-mediated transcription and LCL proliferation, with mutations in the MYND domain abolishing this effect.
Conclusions:
- The C-terminal domains of BS69 act as a direct inhibitor of EBNA2.
- The structural and functional characterization of the BS69-EBNA2 interaction provides insights into EBV pathogenesis.
- This interaction represents a potential target for novel therapeutic strategies against EBV infection.
More Related Videos
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Tail-anchoring of Proteins in the ER Membrane
Master Transcription Regulators
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...

